OncoSec Medical Inc (ONCS):企業の財務・戦略的SWOT分析

◆英語タイトル:OncoSec Medical Inc (ONCS) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH321622FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥68,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥102,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OncoSec Medical Inc (OncoSec) is a biotechnology company. The company offers services to stimulate body’s immune system and attack cancer. Its lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. OncoSec is conducting pipeline programs for various indications which include metastatic melanoma, triple negative breast cancer and solid tumors. The company is also identifying and developing novel immune-targeting agents for use with the immunogenicity platform. It conducts pre-clinical and clinical studies targeting various cancers in collaboration with various academic medical centers and companies. OncoSec is headquartered in San Diego, California, the US.

OncoSec Medical Inc Key Recent Developments

Feb 18,2021: OncoSec appoints Bridget O’Keeffe, Ph.D. as vice president of clinical development
Feb 02,2021: OncoSec strengthens management team with two new appointments
Oct 12,2020: OncoSec announces appointment of Sandra Aung, Ph.D. as Senior Vice President, Chief Clinical Development Officer
Jul 27,2020: OncoSec appoints Kellie Malloy Foerter as chief operating officer
May 14,2020: OncoSec partners with the Melanoma Research Foundation to host live panel discussion during melanoma awareness month

This comprehensive SWOT profile of OncoSec Medical Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of OncoSec Medical Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

OncoSec Medical Inc – Key Information
OncoSec Medical Inc – Overview
OncoSec Medical Inc – Key Employees
OncoSec Medical Inc – Key Employee Biographies
OncoSec Medical Inc – Key Operational Heads
OncoSec Medical Inc – Major Products and Services
OncoSec Medical Inc – History
OncoSec Medical Inc – Company Statement
OncoSec Medical Inc – Locations And Subsidiaries
OncoSec Medical Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

OncoSec Medical Inc – Business Description
OncoSec Medical Inc – Corporate Strategy
OncoSec Medical Inc – SWOT Analysis
SWOT Analysis – Overview
OncoSec Medical Inc – Strengths
OncoSec Medical Inc – Weaknesses
OncoSec Medical Inc – Opportunities
OncoSec Medical Inc – Threats
OncoSec Medical Inc – Key Competitors

Section 3 – Company Financial Performance Charts

OncoSec Medical Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

OncoSec Medical Inc, Key Information
OncoSec Medical Inc, Key Ratios
OncoSec Medical Inc, Share Data
OncoSec Medical Inc, Major Products and Services
OncoSec Medical Inc, History
OncoSec Medical Inc, Key Employees
OncoSec Medical Inc, Key Employee Biographies
OncoSec Medical Inc, Key Operational Heads
OncoSec Medical Inc, Other Locations
OncoSec Medical Inc, Subsidiaries
OncoSec Medical Inc, Key Competitors
OncoSec Medical Inc, SWOT Analysis
OncoSec Medical Inc, Ratios based on current share price
OncoSec Medical Inc, Annual Ratios
OncoSec Medical Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[OncoSec Medical Inc (ONCS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nipro Corp (8086):製薬・医療:M&Aディール及び事業提携情報
    Summary Nipro Corp (Nipro) manufactures, develops and markets pharmaceuticals, medical equipment and functional materials (including glass, rubber and plastic). The company’s products include renal products, interventional and anesthesiology products, injection and infusion products, cardiopulmonary …
  • PetSmart, Inc.:企業の戦略・SWOT・財務情報
    PetSmart, Inc. - Strategy, SWOT and Corporate Finance Report Summary PetSmart, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Waterman Group Plc (WTM):企業の財務・戦略的SWOT分析
    Summary Waterman Group Plc (Waterman), formerly Waterman Partnership Holdings Plc, a subsidiary of CTI Engineering Co Ltd, is an engineering and environmental consultancy service provider that offers services for property, infrastructure, environment and energy markets. The company provides services …
  • Intuitive Surgical Inc (ISRG):医療機器:M&Aディール及び事業提携情報
    Summary Intuitive Surgical Inc (Intuitive Surgical) is a provider of robotic-assisted minimally invasive surgery (MIS) devices. Its portfolio encompasses da Vinci Surgical Systems, InSite and Firefly Fluorescence imaging systems (Firefly), instruments and accessories and training technologies. The d …
  • Relmada Therapeutics Inc (RLMD):製薬・医療:M&Aディール及び事業提携情報
    Summary Relmada Therapeutics Inc (Relmada Therapeutics), formerly Camp Nine Inc, is a pharmaceutical company that develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company’s product pipeline includes REL-1017 d-Methadone, an antagonist for the treat …
  • Restaurant Brands New Zealand Limited
    Restaurant Brands New Zealand Limited - Strategy, SWOT and Corporate Finance Report Summary Restaurant Brands New Zealand Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Centers for Disease Control and Prevention:医療機器:M&Aディール及び事業提携情報
    Summary Centers for Disease Control and Prevention (CDC) a subsidiary of US Department of Health and Human Services is a public health institute that offers health, safety and security threat management solutions. The institute provides health information to fight diseases and support communities fr …
  • Alphatec Holdings Inc (ATEC):医療機器:M&Aディール及び事業提携情報
    Summary Alphatec Holdings Inc (Alphatec) is a medical technology company that focuses on the design, development and marketing of spinal fusion technology products and solutions for the treatment of spine disorders. The company’s major products include anterior cervical plate system, posterior cervi …
  • Metlifecare Ltd (MET)-製薬・医療分野:企業M&A・提携分析
    Summary Metlifecare Ltd (Metlifecare) is a healthcare service provider that owns and manages retirement villages to older citizens in New Zealand. The center provides retirement villages provide services such as healthcare services, security, community and companionship, maintenance free living and …
  • CFM International, Inc.:企業の戦略・SWOT・財務情報
    CFM International, Inc. - Strategy, SWOT and Corporate Finance Report Summary CFM International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Sareum Holdings Plc (SAR):製薬・医療:M&Aディール及び事業提携情報
    Summary Sareum Holdings Plc (Sareum) is a drug discovery and development company that produces targeted small molecule therapeutics for treating cancer and autoimmune diseases. The drug research programs of the company are based on its proprietary drug discovery technology, Sareum Kinase Inhibitor L …
  • London Stock Exchange Group Plc:企業のM&A・事業提携・投資動向
    London Stock Exchange Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's London Stock Exchange Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Cerenis Therapeutics Holding SA (CEREN):製薬・医療:M&Aディール及び事業提携情報
    Summary Cerenis Therapeutics Holding SA (Cerenis) is a biopharmaceutical company that discovers and develops HDL therapies for the treatment of cardiovascular and metabolic diseases. The company develops a portfolio of HDL therapies including HDL mimetics for the rapid regression of atherosclerotic …
  • Maruti Suzuki India Limited:企業の戦略・SWOT・財務分析
    Maruti Suzuki India Limited - Strategy, SWOT and Corporate Finance Report Summary Maruti Suzuki India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Senvion SA:電力:M&Aディール及び事業提携情報
    Summary Senvion S.A. (Senvion) formerly Senvion S.a.r.l, is a renewable energy company that develops, produces and distributes onshore and offshore wind turbines and towers. It also offers project specific solutions such as turnkey, foundation construction, transport and installation, and service an …
  • JGC Holdings Corp (1963)
    JGC Holdings Corp (1963) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Premera Blue Cross:企業の戦略的SWOT分析
    Premera Blue Cross - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Stryker Corporation:企業の戦略・SWOT・財務情報
    Stryker Corporation - Strategy, SWOT and Corporate Finance Report Summary Stryker Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tobishima Corporation:企業の戦略・SWOT・財務情報
    Tobishima Corporation - Strategy, SWOT and Corporate Finance Report Summary Tobishima Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • The Castle Group, Inc.:企業の戦略・SWOT・財務情報
    The Castle Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Castle Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆